Fibronectin promotes tyrosine phosphorylation of paxillin and cell invasiveness in the gastric cancer cell line AGS

Tumori

Volumn 95, Issue 6, 2009, Pages 769-779

  Dan, Li ^a   Jian, Ding ^a   Xiaozhong, Wang ^a   Chengdang, Wang ^a   Ting, Wu ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

Fibronectin; Focal adhesion kinase; Gastric cancer; Invasiveness; Paxillin

Indexed keywords

FIBRONECTIN; FOCAL ADHESION KINASE; PAXILLIN; SMALL INTERFERING RNA; TYROSINE;

ARTICLE; CANCER CELL CULTURE; CANCER STAGING; CANCER TISSUE; CELL INVASION; CELL MOTILITY; CELL STIMULATION; CONTROLLED STUDY; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPRECIPITATION; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RNA INTERFERENCE; STIMULATION; STOMACH CANCER; WESTERN BLOTTING;

EID: 76349090440     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160909500621     Document Type: Article

References (51)

1. Larsson SC, Orsini N, Wolk A: Processed meat consumption and stomach cancer risk: a meta-analysis. J Natl Cancer Inst, 98: 1078-1087, 2006.
2. Alberts SR, Cervantes A, van de Velde CJ: Gastric cancer: epidemiology, pathology and treatment. Ann Oncol, 14: ii31-ii36, 2003.
3. Roder DM: The epidemiology of gastric cancer. Gastric Cancer, 5: 5-11, 2002.
4. Wu CW, Hsieh MC, Lo SS, Tsay SH, Lui WY, P'eng FK: Relation of number of positive lymph nodes to the prognosis of patients with primary gastric adenocarcinoma. Gut, 38: 525-527, 1996.
5. Reddig PJ, Juliano RL: Clinging to life: cell to matrix adhesion and cell survival. Cancer Metastasis Rev, 24: 425-439, 2005.
6. Chan KT, Cortesio CL, Huttenlocher A: Integrins in cell migration. Methods Enzymol, 426: 47-67, 2007.
7. Hu K, Ji L, Applegate KT, Danuser G, Waterman-Storer CM: Differential transmission of actin motion within focal adhesions. Science, 315: 111-115, 2007.
8. Hehlgans S, Haase M, Cordes N: Signalling via integrins: implications for cell survival and anticancer strategies. Biochim Biophys Acta, 1775: 163-180, 2007.
9. Mosher DF: Physiology of fibronectin. Annu Rev Med, 35: 561-575, 1984.
10. Vaheri A, Salonen EM, Vartio T: Fibronectin in formation and degradation of the pericellular matrix. Ciba Found Symp, 114: 111-126, 1985.
11. Hynes R: Molecular biology of fibronectin. Annu Rev Cell Biol, 1: 67-90, 1985.
12. Hynes RO, Yamada KM: Fibronectins: multifunctional modular glycoproteins. J Cell Biol, 95: 369-377, 1982.
13. Humphries MJ, Obara M, Olden K, Yamada KM: Role of fibronectin in adhesion, migration, and metastasis. Cancer Invest, 7: 373-393, 1989.
14. Margolis EJ, Choi JC, Shu WR Liu BC: Specific sequences of fibronectin activate the protein kinase C signal transduction pathway in invasive bladder cancer. Cancer Lett, 100: 163-168, 1996.
15. Ahmed N, Riley C, Rice G, Quinn M: Role of integrin receptors for fibronectin, collagen and laminin in the regulation of ovarian carcinoma functions in response to a matrix microenvironment. Clin Exp Metastasis, 22: 391-402, 2005.
16. Koul D, Shen R, Bergh S, Lu Y, de Groot JF, Liu TJ, Mills GB, Yung WK: Targeting integrin-linked kinase inhibits Akt signaling pathways and decreases tumor progression of human glioblastoma. Mol Cancer Ther, 11: 1681-1688, 2005.
17. Cheng DL, Shu WR Choi JC, Margolis EJ, Droller MJ, Liu BC: Bacillus Calmette-Guerin interacts with the carboxyl-terminal heparin binding domain of fibronectin: implications for BCG-mediated antitumor activity. J Urol, 152: 1275-1280, 1994.
18. Buck CA, Horwitz AF: Cell surface receptors for extracellular matrix molecules. Annu Rev Cell Biol, 3: 179-205, 1987.
19. Akiyama SK: Integrins in cell adhesion and signaling. Hum Cell, 9: 181-186, 1996.
20. Burridge K, Chrzanowska-Wodnicka M: Focal adhesions, contractility, and signaling. Annu Rev Cell Dev Biol, 12: 463-518, 1996.
21. Turner CE: Paxillin interactions. J Cell Sci, 113: 4139-4140, 2000.
22. Turner CE: Paxillin and focal adhesion signalling. Nat Cell Biol, 2: E231-236, 2000.
23. Bellis SL, Perrotta JA, Curtis MS, Turner CE: Adhesion of fibroblasts to fibronectin stimulates both serine and tyrosine phosphorylation of paxillin. Biochem J, 25: 375-381, 1997.
24. Bang OS, Kim EJ, Chung JG, Lee SR, Park TK, Kang SS: Association of focal adhesion kinase with fibronectin and paxillin is required for precartilage condensation of chick mesenchymal cells. Biochem Biophys Res Commun, 278: 522-529, 2000.
25. Salasznyk RM, Klees RF, Williams WA, Boskey A, Plopper GE: Focal adhesion kinase signaling pathways regulate the osteogenic differentiation of human mesenchymal stem cells. Exp Cell Res 2007; 313: 22-37.
26. Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM, McEwan RN: A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res, 47: 3239-3245, 1987.
27. Sattler M, Pisick E, Morrison PT, Salgia R: Role of the cytoskeletal protein paxillin in oncogenesis. Crit Rev Oncog, 11: 63-76, 2000.
28. Weisberg E, Sattler M, Ewaniuk DS, Salgia R: Role of focal adhesion proteins in signal transduction and oncogenesis. Crit Rev Oncog, 8: 343-358, 1997.
29. Salgia R, Avraham S, Pisick E, Li JL, Raja S, Greenfield EA, Sattler M, Avraham H, Griffin JD: The related adhesion focal tyrosine kinase forms a complex with paxillin in hematopoietic cells. J Biol Chem, 271: 31222-31226, 1996.
30. Schaller MD: Paxillin: a focal adhesion-associated adaptor protein. Oncogene, 20: 6459-6472, 2001.
31. Bellis SL, Miller JT, Turner CE: Characterization of tyrosine phosphorylation of paxillin in vitro by focal adhesion kinase. J Biol Chem, 270: 17437-17441, 1995.
32. Schaller MD, Schaefer EM: Multiple stimuli induce tyrosine phosphorylation of the Crk-binding sites of paxillin. Biochem J, 360: 57-66, 2001.
33. Thomas JW, Ellis B, Boerner RJ, Knight WB, White GC 2nd, Schaller MD: SH2- and SH3-mediated interactions between focal adhesion kinase and Src. J Biol Chem, 273: 577-583, 1998.
34. Cooley MA, Broome JM, Ohngemach C, Romer LH, Schaller MD: Paxillin binding is not the sole determinant of focal adhesion localization or dominant-negative activity of focal adhesion kinase/focal adhesion kinase-related nonkinase. Mol Biol Cell, 11: 3247-3263, 2000.
35. Huang C, Jacobson K, Schaller MD: A role for JNK-paxillin signaling in cell migration. Cell Cycle, 3: 4-6, 2004.
36. Tu LC, Chou CK, Chen HC, Yeh SF: Protein kinase C-mediated tyrosine phosphorylation of paxillin and focal adhesion kinase requires cytoskeletal integrity and is uncoupled to mitogen-activated protein kinase activation in human hepatoma cells. J Biomed Sci, 8: 184-190, 2001.
37. Schaller MD: Biochemical signals and biological responses elicited by the focal adhesion kinase. Biochim Biophys Acta, 1540: 1-21, 2001.
38. Yano H, Mazaki Y, Kurokawa K, Hanks SK, Matsuda M, Sabe H: Roles played by a subset of integrin signaling molecules in cadherin-based cell-cell adhesion. J Cell Biol, 166: 283-295, 2004.
39. Schaller MD: FAK and paxillin: regulators of N-cadherin adhesion and inhibitors of cell migration? J Cell Biol, 166: 157-159, 2004.
40. Schlaepfer DD, Broome MA, Hunter T: Fibronectin-stimulated signaling from a focal adhesion kinase-c-Src complex: involvement of the Grb2, p130cas, and Nck adaptor proteins. Mol Cell Biol, 17: 1702-1713, 1997.
41. Brown MC, Cary LA, Jamieson JS, Cooper JA, Turner CE: Src and FAK kinases cooperate to phosphorylate paxillin kinase linker, stimulate its focal adhesion localization, and regulate cell spreading and protrusiveness. Mol Biol Cell, 16: 4316-4328, 2005.
42. Laser M, Willey CD, Jiang W, Cooper G 4th, Menick DR, Zile MR, Kuppuswamy D: Integrin activation and focal complex formation in cardiac hypertrophy. J Biol Chem, 275: 35624-35630, 2000.
43. Gabarra-Niecko V, Schaller MD, Dunty JM: FAK regulates biological processes important for the pathogenesis of cancer. Cancer Metastasis Rev, 22: 359-374, 2003.
44. CAS in canine and feline mammary tumors. Vet Res, 34: 193-202, 2003.
45. Zeng ZZ, Jia Y, Hahn NJ, Markwart SM, Rockwood KF, Livant DL: Role of focal adhesion kinase and phosphatidylinositol 3'-kinase in integrin fibronectin receptor-mediated, matrix metalloproteinase-1-dependent invasion by metastatic prostate cancer cells. Cancer Res, 66: 8091-8099, 2006.
46. McLean GW, Carragher NO, Avizienyte E, Evans J, Brunton VG, Frame MC: The role of focal-adhesion kinase in cancer - a new therapeutic opportunity. Nat Rev Cancer, 5: 505-515, 2005.
47. Hecker TP, Gladson CL: Focal adhesion kinase in cancer. Front Biosci, 8: 705-714, 2003.
48. Mon NN, Ito S, Senga T, Hamaguchi M: FAK signaling in neoplastic disorders: a linkage between inflammation and cancer. Ann N Y Acad Sci, 1086: 199-212, 2006.
49. van Nimwegen MJ, van de Water B: Focal adhesion kinase: a potential target in cancer therapy. Biochem Pharmacol, 73: 597-609, 2007.
50. Webb DJ, Donais K, Whitmore LA, Thomas SM, Turner CE, Parsons JT, Horwitz AF: FAK-Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly. Nat Cell Biol, 6: 154-161, 2004.
51. Cary LA, Chang JF, Guan JL: Stimulation of cell migration by overexpression of focal adhesion kinase and its association with Src and Fyn. J Cell Sci, 109: 1787-1794, 1996.